Michael P. Thirlwell, MD
Primary Axis:
Cancer
Email:
Email contact form Research Focus:
Conducts clinical research in the treatment of solid tumors and the relief of symptoms due to cancer and anti-cancer agents. Particular tumor sites of interest are breast and colorectal cancers.Cancer clinical trials, breast cancer, colorectal cancer, supportive care
Keywords:
Cancer clinical trials, breast cancer, colorectal cancer, supportive care
Location:
Montreal General Hospital Publications:
Thirlwell M, Nercessian A, Legler C, Duero D, Ayoub J, Cragg L, Hings I. A pilot study of a new scalp cooling system to reduce alopecia in cancer patients receiving chemotherapy. Proceedings of the 17th International Congress of UICC 1998; 2: 1457-1459.
Frenette PS, Thirlwell MP, Trudeau M, Thomson DMP, Joseph L, Shuster JS. The Diagnostic Value of A 27-29, CA 15-3, Mucin-Like Carcinoma Antigen (MCA), Carcinembrionic Antigen (CEA) and CA 19-9 in Breast and Gastrointestinal Malignancies. Tumor Biology 1994; 15: 247-254.
Wolmark N, Rockette H, Wickerman D, Fisher B, Redmond C, Fisher ER, Potvin M, Davies RJ, Jones J, Robidoux A, Wexler M, Gordon P, Cruz AB, Horsley S Jr, Nims TA, Thirlwell M, Phillips WA, Prager D, Stern H, Lerner HJ, Frazier TG. Adjuvant Therapy of Duke’s A, B and C Adenocarcinoma of the Colon with Portal-Vein Fluorouracil Hepatic Infusion: Preliminary Results of National Surgical Adjuvant Breast and Bowel Project. Journal of Clinical Oncology 1990; 8:1466-1475.
